AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, real estate, Bitcoin & more
All-In with Chamath, Jason, Sacks & Friedberg
Antibody Therape - Should We Be Charged 56 Thousand Dollars?
There's no risk to taking this drug. So it's all about the cost and the upside. The downsight and the side at is negligible. There's 15 million people in the united states, with all simers, they're going to raise their hand and say, oh my god, anything that gives me any chance or any hope, i want to get but if it costs 56 thousand dollars? And thenpart, you know, second issue is like, should this thing have been approved when it wasn't really that efficacious?
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode